These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4035555)

  • 41. Studies on the influence of selective adenomectomy on hormone secretion from normal anterior pituitary gland.
    Popp G; Stracke H; Hildebrandt G; Schatz H
    Pathol Res Pract; 1988 Sep; 183(5):540-5. PubMed ID: 2853333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
    Freda PU; Wardlaw SL; Post KD
    J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acromegaly with normal growth-hormone levels and pituitary histology. Case report.
    Feingold KR; Goldfine ID; Weinstein PR
    J Neurosurg; 1979 Apr; 50(4):503-7. PubMed ID: 106097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of invasive growth hormone pituitary adenomas with long-acting somatostatin analog SMS 201-995 before transsphenoidal surgery.
    Lucas-Morante T; García-Uría J; Estrada J; Saucedo G; Cabello A; Alcañiz J; Barceló B
    J Neurosurg; 1994 Jul; 81(1):10-4. PubMed ID: 8207509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Presurgical octreotide treatment in acromegaly.
    Stevenaert A; Harris AG; Kovacs K; Beckers A
    Metabolism; 1992 Sep; 41(9 Suppl 2):51-8. PubMed ID: 1518434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrence following transsphenoidal surgery for acromegaly.
    Buchfelder M; Brockmeier S; Fahlbusch R; Honegger J; Pichl J; Manzl M
    Horm Res; 1991; 35(3-4):113-8. PubMed ID: 1806464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Criteria for cure in acromegaly: report of a case apparently cured in which persisting tumor was found at autopsy.
    Wrightson P; Holdaway IM; Synek BJ
    Neurosurgery; 1984 Jun; 14(6):750-5. PubMed ID: 6379495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.
    Lissett CA; Peacey SR; Laing I; Tetlow L; Davis JR; Shalet SM
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):653-7. PubMed ID: 10197082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of long-term remission of acromegaly following surgery.
    Krieger MD; Couldwell WT; Weiss MH
    J Neurosurg; 2003 Apr; 98(4):719-24. PubMed ID: 12691394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in pituitary hormones during and following transsphenoidal removal of prolactinomas.
    Casper RF; Rakoff JS; Quigley ME; Gilliland B; Alksne J; Yen SS
    Am J Obstet Gynecol; 1980 Feb; 136(4):518-23. PubMed ID: 6766667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transsphenoidal microsurgery in the treatment of acromegaly and gigantism.
    Arafah BU; Brodkey JS; Kaufman B; Velasco M; Manni A; Pearson OH
    J Clin Endocrinol Metab; 1980 Mar; 50(3):578-85. PubMed ID: 6244327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of acromegaly by transsphenoidal microsurgery.
    Giovanelli MA; Motti ED; Paracchi A; Beck-Peccoz P; Ambrosi B; Faglia G
    J Neurosurg; 1976 Jun; 44(6):677-86. PubMed ID: 818343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin.
    De Marinis L; Zuppi P; Valle D; Mancini A; Bianchi A; Lauriola L; Pasquini P; Anile C; Maira G; Giustina A
    Horm Metab Res; 2002 Mar; 34(3):137-43. PubMed ID: 11972303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center.
    Bacigaluppi S; Gatto F; Anania P; Bragazzi NL; Rossi DC; Benvegnu G; Nazzari E; Spaziante R; Giusti M; Ferone D; Zona G
    Endocrine; 2016 Mar; 51(3):524-33. PubMed ID: 25982150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The treatment of acromegaly by transsphenoidal surgery.
    Tucker HS; Grubb SR; Wigand JP; Watlington CO; Blackard WG; Becker DP
    Arch Intern Med; 1980 Jun; 140(6):795-802. PubMed ID: 7387274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term follow-up of patients with surgical intractable acromegaly after linear accelerator radiosurgery.
    Yan JL; Chang CN; Chuang CC; Hsu PW; Lin JD; Wei KC; Lee ST; Tseng JK; Pai PC; Chen YL
    J Formos Med Assoc; 2013 Jul; 112(7):416-20. PubMed ID: 23927981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failure of selective pituitary adenomectomy to cure acromegaly.
    Mims RB; Weiss MH
    J Natl Med Assoc; 1977 May; 69(5):295-9. PubMed ID: 864768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective total removal of a growth-hormone-secreting adenoma: evidence that acromegaly is a primary pituitary disease.
    Wanski ZJ; Robinson AG; Jannetta PJ
    Metabolism; 1979 Jun; 28(6):624-8. PubMed ID: 221785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.